_id
69171b163c536f8df23165f4
Ticker
SYUP
Name
ANBC INC
Exchange
PINK
Address
No 2020 Huqingping Road, Shanghai, China, 201702
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
-
Description
Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral solution that relieves cough and dyspnea; Shen-bao, a syrup for the treatment of impotence and spermatorrhoea; Ban-xia, a syrup that relieves cough; and Gan-mao-zhi-ke, a syrup that relieves flu symptoms, cough, and nasal congestion. It also offers Ban-lan-gen that relieves cold and flu symptoms; Gan-mao-qing-re that relieves minor body aches and pains, and reduces fever; Huang-dan-yin-chen used in the treatment for jaundice infection hepatitis; and Liu-shen-qu for treatment of vomitings and dysentery. It offers its products to distributors on a wholesale basis. The company is based in Shanghai, China.
Last Close
0.0002
Volume
-
Current Price
0.0002
Change
0
Last Updated
2026-01-07T12:45:56.196Z
Image
-
Ipo Date
-
Market Cap
15920
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2007-12-31
Revenue
5352
Cost Of Revenue
-19534
Gross Profit
24886
Operating Expenses
-38032
Operating Income
43384
Interest Expense
106231
Pretax Income
-62847
Net Income
-62847
Eps
-
Dividends Per Share
-
Shares Outstanding
79604759
Income Tax Expense
0
EBITDA
-
Operating Margin
810.6128550074737
Total Other Income Expense Net
-106231
Cash
10340
Short Term Investments
-
Receivables
8575
Inventories
128238
Total Current Assets
1212721
Property Plant Equipment
5068236
Total Assets
6280957
Payables
1041332
Short Term Debt
3565972
Long Term Debt
205350
Total Liabilities
4812654
Equity
1468303
Bs_currency_symbol
USD
Depreciation
12438
Change In Working Capital
-
Cash From Operations
315963
Capital Expenditures
178462
Cash From Investing
-178462
Cash From Financing
-139116
Net Change In Cash
-1615
Cf_currency_symbol
USD
PE
-
PB
-
ROE
-4.280247333145815
ROA
-1.0005959282956403
FCF
137501
Fcf Percent
25.691517189835576
Piotroski FScore
2
Health Score
37
Deep Value Investing Score
4.5
Defensive Investing Score
4
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
4
Net Net Investing Score
3.5
Quality Investing Score
3
Value Investing Score
1.5
Quarters > 0 > quarter
2007-12-31
Quarters > 0 > income Statement > revenue
5352
Quarters > 0 > income Statement > cost Of Revenue
-19534
Quarters > 0 > income Statement > gross Profit
24886
Quarters > 0 > income Statement > operating Expenses
-38032
Quarters > 0 > income Statement > operating Income
43384
Quarters > 0 > income Statement > interest Expense
106231
Quarters > 0 > income Statement > pretax Income
-62847
Quarters > 0 > income Statement > net Income
-62847
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
810.6128550074737
Quarters > 0 > income Statement > total Other Income Expense Net
-106231
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
10340
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
8575
Quarters > 0 > balance Sheet > inventories
128238
Quarters > 0 > balance Sheet > total Current Assets
1212721
Quarters > 0 > balance Sheet > property Plant Equipment
5068236
Quarters > 0 > balance Sheet > total Assets
6280957
Quarters > 0 > balance Sheet > payables
1041332
Quarters > 0 > balance Sheet > short Term Debt
3565972
Quarters > 0 > balance Sheet > long Term Debt
205350
Quarters > 0 > balance Sheet > total Liabilities
4812654
Quarters > 0 > balance Sheet > equity
1468303
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-62847
Quarters > 0 > cash Flow > depreciation
12438
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
315963
Quarters > 0 > cash Flow > capital Expenditures
178462
Quarters > 0 > cash Flow > cash From Investing
-178462
Quarters > 0 > cash Flow > cash From Financing
-139116
Quarters > 0 > cash Flow > net Change In Cash
-1615
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-4.280247333145815
Quarters > 0 > ratios > ROA
-1.0005959282956403
Quarters > 0 > ratios > FCF
137501
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
25.691517189835576
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2007-09-30
Quarters > 1 > income Statement > revenue
5439
Quarters > 1 > income Statement > cost Of Revenue
-23760
Quarters > 1 > income Statement > gross Profit
29199
Quarters > 1 > income Statement > operating Expenses
60197
Quarters > 1 > income Statement > operating Income
-54758
Quarters > 1 > income Statement > interest Expense
52889
Quarters > 1 > income Statement > pretax Income
-107647
Quarters > 1 > income Statement > net Income
-107647
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-1006.7659496230925
Quarters > 1 > income Statement > total Other Income Expense Net
-52889
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
11955
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2680
Quarters > 1 > balance Sheet > inventories
104903
Quarters > 1 > balance Sheet > total Current Assets
1167735
Quarters > 1 > balance Sheet > property Plant Equipment
4902211
Quarters > 1 > balance Sheet > total Assets
6069946
Quarters > 1 > balance Sheet > payables
910610
Quarters > 1 > balance Sheet > short Term Debt
3478990
Quarters > 1 > balance Sheet > long Term Debt
199712
Quarters > 1 > balance Sheet > total Liabilities
4589312
Quarters > 1 > balance Sheet > equity
1480634
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-107647
Quarters > 1 > cash Flow > depreciation
127427
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
64476
Quarters > 1 > cash Flow > capital Expenditures
116390
Quarters > 1 > cash Flow > cash From Investing
-116390
Quarters > 1 > cash Flow > cash From Financing
50576
Quarters > 1 > cash Flow > net Change In Cash
-1338
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-7.270331493130645
Quarters > 1 > ratios > ROA
-1.7734424655507643
Quarters > 1 > ratios > FCF
-51914
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-9.544769259054974
Quarters > 1 > health Score
19
Quarters > 2 > quarter
2007-06-30
Quarters > 2 > income Statement > revenue
20078
Quarters > 2 > income Statement > cost Of Revenue
7723
Quarters > 2 > income Statement > gross Profit
12355
Quarters > 2 > income Statement > operating Expenses
89809
Quarters > 2 > income Statement > operating Income
-69732
Quarters > 2 > income Statement > interest Expense
36145
Quarters > 2 > income Statement > pretax Income
-105876
Quarters > 2 > income Statement > net Income
-105876
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-347.3055085167845
Quarters > 2 > income Statement > total Other Income Expense Net
-36145
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
13293
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
87559
Quarters > 2 > balance Sheet > total Current Assets
1103673
Quarters > 2 > balance Sheet > property Plant Equipment
4913249
Quarters > 2 > balance Sheet > total Assets
6016922
Quarters > 2 > balance Sheet > payables
825549
Quarters > 2 > balance Sheet > short Term Debt
3431160
Quarters > 2 > balance Sheet > long Term Debt
196967
Quarters > 2 > balance Sheet > total Liabilities
4453676
Quarters > 2 > balance Sheet > equity
1563246
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-105876
Quarters > 2 > cash Flow > depreciation
65285
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-35082
Quarters > 2 > cash Flow > capital Expenditures
60223
Quarters > 2 > cash Flow > cash From Investing
-60223
Quarters > 2 > cash Flow > cash From Financing
44883
Quarters > 2 > cash Flow > net Change In Cash
-50422
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-6.772830379863438
Quarters > 2 > ratios > ROA
-1.7596372364474728
Quarters > 2 > ratios > FCF
-95305
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-4.7467377228807655
Quarters > 2 > health Score
22
Quarters > 3 > quarter
2007-03-31
Quarters > 3 > income Statement > revenue
20078
Quarters > 3 > income Statement > cost Of Revenue
7723
Quarters > 3 > income Statement > gross Profit
12355
Quarters > 3 > income Statement > operating Expenses
89809
Quarters > 3 > income Statement > operating Income
-69732
Quarters > 3 > income Statement > interest Expense
36145
Quarters > 3 > income Statement > pretax Income
-105876
Quarters > 3 > income Statement > net Income
-105876
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-347.3055085167845
Quarters > 3 > income Statement > total Other Income Expense Net
-36145
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
13293
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
87559
Quarters > 3 > balance Sheet > total Current Assets
1103673
Quarters > 3 > balance Sheet > property Plant Equipment
4913249
Quarters > 3 > balance Sheet > total Assets
6016922
Quarters > 3 > balance Sheet > payables
825549
Quarters > 3 > balance Sheet > short Term Debt
3431160
Quarters > 3 > balance Sheet > long Term Debt
196967
Quarters > 3 > balance Sheet > total Liabilities
4453676
Quarters > 3 > balance Sheet > equity
1563246
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-105876
Quarters > 3 > cash Flow > depreciation
65285
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-35082
Quarters > 3 > cash Flow > capital Expenditures
60223
Quarters > 3 > cash Flow > cash From Investing
-60223
Quarters > 3 > cash Flow > cash From Financing
44883
Quarters > 3 > cash Flow > net Change In Cash
-50422
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-6.772830379863438
Quarters > 3 > ratios > ROA
-1.7596372364474728
Quarters > 3 > ratios > FCF
-95305
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-4.7467377228807655
Quarters > 3 > health Score
22
Annuals > 0 > quarter
2017-12-31
Annuals > 0 > income Statement > revenue
3155249
Annuals > 0 > income Statement > cost Of Revenue
1605250
Annuals > 0 > income Statement > gross Profit
1550000
Annuals > 0 > income Statement > operating Expenses
198637
Annuals > 0 > income Statement > operating Income
1351360
Annuals > 0 > income Statement > interest Expense
83.18
Annuals > 0 > income Statement > pretax Income
1337546
Annuals > 0 > income Statement > net Income
1298104
Annuals > 0 > income Statement > eps
0.01630686426674566
Annuals > 0 > income Statement > dividends Per Share
681298
Annuals > 0 > income Statement > shares Outstanding
79604759
Annuals > 0 > income Statement > income Tax Expense
39442
Annuals > 0 > income Statement > EBITDA
1449364
Annuals > 0 > income Statement > operating Margin
42.8289494743521
Annuals > 0 > income Statement > total Other Income Expense Net
-13814
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
78867
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1689425
Annuals > 0 > balance Sheet > inventories
453440
Annuals > 0 > balance Sheet > total Current Assets
2221733
Annuals > 0 > balance Sheet > property Plant Equipment
450671
Annuals > 0 > balance Sheet > total Assets
2672404
Annuals > 0 > balance Sheet > payables
290121
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
809211
Annuals > 0 > balance Sheet > equity
1863193
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
1298104
Annuals > 0 > cash Flow > depreciation
111733
Annuals > 0 > cash Flow > change In Working Capital
-614738
Annuals > 0 > cash Flow > cash From Operations
795099
Annuals > 0 > cash Flow > capital Expenditures
48850
Annuals > 0 > cash Flow > cash From Investing
-48850
Annuals > 0 > cash Flow > cash From Financing
-681298
Annuals > 0 > cash Flow > net Change In Cash
67783
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.01630686426674566
Annuals > 0 > ratios > PB
0.008544982618547838
Annuals > 0 > ratios > ROE
69.67093586118024
Annuals > 0 > ratios > ROA
48.57439219519205
Annuals > 0 > ratios > FCF
746249
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.23651033563436674
Annuals > 0 > health Score
93
Annuals > 1 > quarter
2016-12-31
Annuals > 1 > income Statement > revenue
2867721
Annuals > 1 > income Statement > cost Of Revenue
1497804
Annuals > 1 > income Statement > gross Profit
1369917
Annuals > 1 > income Statement > operating Expenses
127706
Annuals > 1 > income Statement > operating Income
1242210
Annuals > 1 > income Statement > interest Expense
290.41
Annuals > 1 > income Statement > pretax Income
1242015
Annuals > 1 > income Statement > net Income
1211478
Annuals > 1 > income Statement > eps
0.05607396436010183
Annuals > 1 > income Statement > dividends Per Share
681299
Annuals > 1 > income Statement > shares Outstanding
21605000
Annuals > 1 > income Statement > income Tax Expense
30537
Annuals > 1 > income Statement > EBITDA
1355454
Annuals > 1 > income Statement > operating Margin
43.31697539614209
Annuals > 1 > income Statement > total Other Income Expense Net
-195
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
11084
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1006709
Annuals > 1 > balance Sheet > inventories
152828
Annuals > 1 > balance Sheet > total Current Assets
1170623
Annuals > 1 > balance Sheet > property Plant Equipment
486274
Annuals > 1 > balance Sheet > total Assets
1656897
Annuals > 1 > balance Sheet > payables
99161
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
500881
Annuals > 1 > balance Sheet > equity
1156016
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
1211478
Annuals > 1 > cash Flow > depreciation
113146
Annuals > 1 > cash Flow > change In Working Capital
-1330877
Annuals > 1 > cash Flow > cash From Operations
-6252.63
Annuals > 1 > cash Flow > capital Expenditures
48850
Annuals > 1 > cash Flow > cash From Investing
16485
Annuals > 1 > cash Flow > cash From Financing
-681299
Annuals > 1 > cash Flow > net Change In Cash
10232
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.05607396436010183
Annuals > 1 > ratios > PB
0.003737837538580781
Annuals > 1 > ratios > ROE
104.79768446111473
Annuals > 1 > ratios > ROA
73.11727886525233
Annuals > 1 > ratios > FCF
-55102.63
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.019214780656835167
Annuals > 1 > health Score
73
Annuals > 2 > quarter
2015-12-31
Annuals > 2 > income Statement > revenue
2159914
Annuals > 2 > income Statement > cost Of Revenue
1035236
Annuals > 2 > income Statement > gross Profit
1124677
Annuals > 2 > income Statement > operating Expenses
0
Annuals > 2 > income Statement > operating Income
812759
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
806406
Annuals > 2 > income Statement > net Income
783585
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
681299
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
22822
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
37.62922968229291
Annuals > 2 > income Statement > total Other Income Expense Net
-6194
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
37730
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
223802
Annuals > 2 > balance Sheet > inventories
96776
Annuals > 2 > balance Sheet > total Current Assets
358309
Annuals > 2 > balance Sheet > property Plant Equipment
615907
Annuals > 2 > balance Sheet > total Assets
974215
Annuals > 2 > balance Sheet > payables
992798
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
992798
Annuals > 2 > balance Sheet > equity
-18583
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
783585
Annuals > 2 > cash Flow > depreciation
123617
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
54679
Annuals > 2 > cash Flow > capital Expenditures
33429
Annuals > 2 > cash Flow > cash From Investing
-33429
Annuals > 2 > cash Flow > cash From Financing
-681299
Annuals > 2 > cash Flow > net Change In Cash
21250
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-4216.676532314481
Annuals > 2 > ratios > ROA
80.43245074239259
Annuals > 2 > ratios > FCF
21250
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.00983835467523244
Annuals > 2 > health Score
36
Annuals > 3 > quarter
2007-12-31
Annuals > 3 > income Statement > revenue
50946
Annuals > 3 > income Statement > cost Of Revenue
234917
Annuals > 3 > income Statement > gross Profit
-183971
Annuals > 3 > income Statement > operating Expenses
18
Annuals > 3 > income Statement > operating Income
-183990
Annuals > 3 > income Statement > interest Expense
231409
Annuals > 3 > income Statement > pretax Income
-382246
Annuals > 3 > income Statement > net Income
-382246
Annuals > 3 > income Statement > eps
-0.017692478592918306
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
21605000
Annuals > 3 > income Statement > income Tax Expense
-7
Annuals > 3 > income Statement > EBITDA
-26275
Annuals > 3 > income Statement > operating Margin
-361.14709692615713
Annuals > 3 > income Statement > total Other Income Expense Net
-198257
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
10340
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
8575
Annuals > 3 > balance Sheet > inventories
128237
Annuals > 3 > balance Sheet > total Current Assets
1212721
Annuals > 3 > balance Sheet > property Plant Equipment
5068236
Annuals > 3 > balance Sheet > total Assets
6280957
Annuals > 3 > balance Sheet > payables
1041331
Annuals > 3 > balance Sheet > short Term Debt
3565972
Annuals > 3 > balance Sheet > long Term Debt
205350
Annuals > 3 > balance Sheet > total Liabilities
4812654
Annuals > 3 > balance Sheet > equity
1468303
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-382246
Annuals > 3 > cash Flow > depreciation
-270435
Annuals > 3 > cash Flow > change In Working Capital
70887
Annuals > 3 > cash Flow > cash From Operations
78541
Annuals > 3 > cash Flow > capital Expenditures
415298
Annuals > 3 > cash Flow > cash From Investing
-415298
Annuals > 3 > cash Flow > cash From Financing
232961
Annuals > 3 > cash Flow > net Change In Cash
-103796
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.017692478592918306
Annuals > 3 > ratios > PB
0.002942853075965928
Annuals > 3 > ratios > ROE
-26.033182524315485
Annuals > 3 > ratios > ROA
-6.0857923402436915
Annuals > 3 > ratios > FCF
-336757
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-6.610077336787971
Annuals > 3 > health Score
17
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-4.280247333145815
Profitability > metrics > ROA
-5.182313161889668
Profitability > metrics > Net Margin
-11.742713004484305
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.2776981317888745
Risk > metrics > Interest Coverage
0.4083930302830624
Risk > final Score
8
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.2632170570902202
Liquidity > metrics > Quick Ratio
0.23538342596885292
Liquidity > final Score
22
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
2
Prev Risks > 1
10
Prev Risks > 2
10
Prev Liquidities > 0
22
Prev Liquidities > 1
22
Prev Liquidities > 2
22
Updated At
2026-01-20T22:39:48.920Z
Earnings History > 0 > period
2006-09-30
Earnings History > 0 > report Date
2006-09-30
Earnings History > 0 > date
2006-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.0283
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2006-06-30
Earnings History > 1 > report Date
2006-06-30
Earnings History > 1 > date
2006-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0036
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2006-03-31
Earnings History > 2 > report Date
2006-03-31
Earnings History > 2 > date
2006-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0024
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2005-12-31
Earnings History > 3 > report Date
2005-12-31
Earnings History > 3 > date
2005-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0678
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2005-09-30
Earnings History > 4 > report Date
2005-09-30
Earnings History > 4 > date
2005-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.0043
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Shanghai Yutong Pharma, Inc. engages in the development, manufacturing, and commercialization of traditional Chinese herbal medicines and biological pharmaceuticals in the People's Republic of China. Its products primarily include Qilisheng a product formulated to be a general health enhancer by fortifying the immune system; Qi-ju-di-huang, an oral solution that protects the kidney and the liver; Qing-re-jie-du, an oral solution that reduces fever and relieves heat; Sheng-mai-yin, a solution that protects energy and enhances body fluids; Xiao-qing-long, an oral solution that relieves cough and dyspnea; Shen-bao, a syrup for the treatment of impotence and spermatorrhoea; Ban-xia, a syrup that relieves cough; and Gan-mao-zhi-ke, a syrup that relieves flu symptoms, cough, and nasal congestion. It also offers Ban-lan-gen that relieves cold and flu symptoms; Gan-mao-qing-re that relieves minor body aches and pains, and reduces fever; Huang-dan-yin-chen used in the treatment for jaundice infection hepatitis; and Liu-shen-qu for treatment of vomitings and dysentery. It offers its products to distributors on a wholesale basis. The company is based in Shanghai, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACough Syrup Trafficking Syndicate: Abbott Under Scrutiny After ₹100-Crore Stock Redirected to Ranchi The420.in
Read more →Showing 2 of 10
(Last Updated 2007-12-31)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of ANBC INC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2006-09-30
EPS Actual
-0.0283
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2007-12-31)
(Last Updated 2007-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2007-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2007-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.